Arkolith/Insider Trading/MPLT/Form 4

Kroeger Christopher A.

Chief Executive Officer, DirectorMapLight Therapeutics, Inc. (MPLT) · full profile →Form 4 · filed Oct 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Conversion(C)4K——230K
Oct 27, 2025Grant(A)226K—$0226K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 28, 2025Conversion(C)65K—$00
Oct 27, 2025Grant(A)916K—$0916K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001658918-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML